Do analysts prefer AIMDW or FTH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00

Which has stronger valuation and earnings, AIMDW or FTH?

Ainos has higher revenue and earnings than Sensei Biotherapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $18.11K N/A N/A N/A N/A Sensei Biotherapeutics N/A N/A -$21.08M N/A N/A

Is AIMDW or FTH more profitable?

Ainos' return on equity of 0.00% beat Sensei Biotherapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Ainos N/A N/A N/A Sensei Biotherapeutics N/A -83.59% -256.50%

Do analysts rate FTH or ALVOW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Alvotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, FTH or ALVOW?

Alvotech has higher revenue and earnings than Sensei Biotherapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sensei Biotherapeutics N/A N/A -$21.08M N/A N/A Alvotech $559.42M N/A N/A N/A N/A

Is FTH or ALVOW more profitable?

Alvotech's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Sensei Biotherapeutics N/A -83.59% -256.50% Alvotech N/A N/A N/A

Do analysts prefer ARAV or FTH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aravive 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00

Which has stronger valuation and earnings, ARAV or FTH?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A Sensei Biotherapeutics N/A N/A -$21.08M N/A N/A

Is ARAV or FTH more profitable?

Aravive's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A Sensei Biotherapeutics N/A -83.59% -256.50%

Do analysts prefer FTH or ACABW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Atlantic Coastal Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings and valuation, FTH or ACABW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sensei Biotherapeutics N/A N/A -$21.08M N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A

Is FTH or ACABW more profitable?

Atlantic Coastal Acquisition Corp. II's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Sensei Biotherapeutics N/A -83.59% -256.50% Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Do analysts rate BFRIW or FTH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biofrontera 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00

Which has preferable valuation and earnings, BFRIW or FTH?

Biofrontera has higher revenue and earnings than Sensei Biotherapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $43.20M N/A N/A N/A N/A Sensei Biotherapeutics N/A N/A -$21.08M N/A N/A

Is BFRIW or FTH more profitable?

Biofrontera's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Biofrontera N/A N/A N/A Sensei Biotherapeutics N/A -83.59% -256.50%

Sensei Biotherapeutics (FTH) Competitors

$16.65 +2.12 (+14.59%)

As of 04:00 PM Eastern

Compare

FTH vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Sensei Biotherapeutics stock or one of its competitors? MarketBeat compares Sensei Biotherapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sensei Biotherapeutics include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Sensei Biotherapeutics compare to Ainos?

Ainos (NASDAQ:AIMDW) and Sensei Biotherapeutics (NASDAQ:FTH) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

In the previous week, Ainos' average media sentiment score of 1.87 beat Sensei Biotherapeutics' score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company	Overall Sentiment
Ainos	Very Positive
Sensei Biotherapeutics	Neutral

10.5% of Sensei Biotherapeutics shares are owned by institutional investors. 7.0% of Sensei Biotherapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Ainos' return on equity of 0.00% beat Sensei Biotherapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Sensei Biotherapeutics	N/A	-83.59%	-256.50%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sensei Biotherapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Ainos has higher revenue and earnings than Sensei Biotherapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$18.11K	N/A	N/A	N/A	N/A
Sensei Biotherapeutics	N/A	N/A	-$21.08M	N/A	N/A

Summary

Ainos and Sensei Biotherapeutics tied by winning 4 of the 8 factors compared between the two stocks.

How does Sensei Biotherapeutics compare to Alvotech?

Sensei Biotherapeutics (NASDAQ:FTH) and Alvotech (NASDAQ:ALVOW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

10.5% of Sensei Biotherapeutics shares are owned by institutional investors. 7.0% of Sensei Biotherapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Alvotech's average media sentiment score of 1.89 beat Sensei Biotherapeutics' score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Sensei Biotherapeutics	Neutral
Alvotech	Very Positive

Alvotech has higher revenue and earnings than Sensei Biotherapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensei Biotherapeutics	N/A	N/A	-$21.08M	N/A	N/A
Alvotech	$559.42M	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensei Biotherapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Alvotech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Alvotech's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensei Biotherapeutics	N/A	-83.59%	-256.50%
Alvotech	N/A	N/A	N/A

Summary

Sensei Biotherapeutics and Alvotech tied by winning 4 of the 8 factors compared between the two stocks.

How does Sensei Biotherapeutics compare to Aravive?

Aravive (NASDAQ:ARAV) and Sensei Biotherapeutics (NASDAQ:FTH) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
Sensei Biotherapeutics	N/A	N/A	-$21.08M	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. Comparatively, 10.5% of Sensei Biotherapeutics shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Comparatively, 7.0% of Sensei Biotherapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aravive's average media sentiment score of 0.00 equaled Sensei Biotherapeutics'average media sentiment score.

Company	Overall Sentiment
Aravive	Neutral
Sensei Biotherapeutics	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aravive	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sensei Biotherapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Aravive's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Sensei Biotherapeutics	N/A	-83.59%	-256.50%

Summary

Aravive beats Sensei Biotherapeutics on 4 of the 6 factors compared between the two stocks.

How does Sensei Biotherapeutics compare to Atlantic Coastal Acquisition Corp. II?

Sensei Biotherapeutics (NASDAQ:FTH) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensei Biotherapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Atlantic Coastal Acquisition Corp. II	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensei Biotherapeutics	N/A	N/A	-$21.08M	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

In the previous week, Sensei Biotherapeutics' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company	Overall Sentiment
Sensei Biotherapeutics	Neutral
Atlantic Coastal Acquisition Corp. II	Neutral

Atlantic Coastal Acquisition Corp. II's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensei Biotherapeutics	N/A	-83.59%	-256.50%
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

Summary

Sensei Biotherapeutics beats Atlantic Coastal Acquisition Corp. II on 4 of the 6 factors compared between the two stocks.

How does Sensei Biotherapeutics compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Sensei Biotherapeutics (NASDAQ:FTH) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

10.5% of Sensei Biotherapeutics shares are held by institutional investors. 7.0% of Sensei Biotherapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biofrontera	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sensei Biotherapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Biofrontera's return on equity of 0.00% beat Sensei Biotherapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Sensei Biotherapeutics	N/A	-83.59%	-256.50%

Biofrontera has higher revenue and earnings than Sensei Biotherapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$43.20M	N/A	N/A	N/A	N/A
Sensei Biotherapeutics	N/A	N/A	-$21.08M	N/A	N/A

In the previous week, Biofrontera's average media sentiment score of 1.87 beat Sensei Biotherapeutics' score of 0.00 indicating that Biofrontera is being referred to more favorably in the media.

Company	Overall Sentiment
Biofrontera	Very Positive
Sensei Biotherapeutics	Neutral

Summary

Biofrontera and Sensei Biotherapeutics tied by winning 4 of the 8 factors compared between the two stocks.

Get Sensei Biotherapeutics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTH vs. The Competition

Export

Metric	Sensei Biotherapeutics	Pharmaceutical Preparations Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$19.50M	$941.52M	$4.35B	$12.23B
Dividend Yield	N/A	4.84%	10.67%	5.71%
P/E Ratio	N/A	1.42	21.98	24.08
Price / Sales	N/A	127.19	155.66	110.27
Price / Cash	N/A	20.06	40.55	55.48
Price / Book	1.13	7.82	22.69	6.61
Net Income	-$21.08M	-$3.94M	$115.37M	$337.89M
7 Day Performance	N/A	2.39%	2.04%	1.65%
1 Month Performance	N/A	2.17%	0.49%	3.10%
1 Year Performance	N/A	44.27%	13.92%	29.69%

Sensei Biotherapeutics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTH Sensei Biotherapeutics	N/A	$16.65 +14.6%	N/A	N/A	$19.50M	N/A	N/A	40	Gap Down High Trading Volume
AIMDW Ainos	N/A	$0.13 -12.4%	N/A	+52.0%	$0.00	$18.11K	N/A	40
ALVOW Alvotech	N/A	$0.33 flat	N/A	-80.6%	$0.00	$559.42M	N/A	4	Positive News
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTH) was last updated on 6/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sensei Biotherapeutics (FTH) Competitors

FTH vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

How does Sensei Biotherapeutics compare to Ainos?

Summary

How does Sensei Biotherapeutics compare to Alvotech?

Summary

How does Sensei Biotherapeutics compare to Aravive?

Summary

How does Sensei Biotherapeutics compare to Atlantic Coastal Acquisition Corp. II?

Summary

How does Sensei Biotherapeutics compare to Biofrontera?

Summary

Media Sentiment Over Time

FTH vs. The Competition

Sensei Biotherapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sensei Biotherapeutics (FTH) Competitors

FTH vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

How does Sensei Biotherapeutics compare to Ainos?

Does the media favor AIMDW or FTH?

Do insiders & institutionals hold more shares of AIMDW or FTH?

Is AIMDW or FTH more profitable?

Do analysts prefer AIMDW or FTH?

Which has stronger valuation and earnings, AIMDW or FTH?

Summary

How does Sensei Biotherapeutics compare to Alvotech?

Do institutionals & insiders hold more shares of FTH or ALVOW?

Does the media prefer FTH or ALVOW?

Which has higher valuation & earnings, FTH or ALVOW?

Do analysts rate FTH or ALVOW?

Is FTH or ALVOW more profitable?

Summary

How does Sensei Biotherapeutics compare to Aravive?

Which has stronger valuation and earnings, ARAV or FTH?

Do insiders and institutionals have more ownership in ARAV or FTH?

Does the media prefer ARAV or FTH?

Do analysts prefer ARAV or FTH?

Is ARAV or FTH more profitable?

Summary

How does Sensei Biotherapeutics compare to Atlantic Coastal Acquisition Corp. II?

Do analysts prefer FTH or ACABW?

Which has preferable earnings and valuation, FTH or ACABW?

Does the media favor FTH or ACABW?

Do institutionals & insiders have more ownership in FTH or ACABW?

Is FTH or ACABW more profitable?

Summary

How does Sensei Biotherapeutics compare to Biofrontera?

Do institutionals and insiders have more ownership in BFRIW or FTH?

Do analysts rate BFRIW or FTH?

Is BFRIW or FTH more profitable?

Which has preferable valuation and earnings, BFRIW or FTH?

Does the media prefer BFRIW or FTH?

Summary

Media Sentiment Over Time

FTH vs. The Competition

Sensei Biotherapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools